These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37532023)

  • 21. The association between ambulatory systolic blood pressure and cardiovascular events in a selected population with intensive control of cardiovascular risk factors.
    Rock W; Leshno M; Shlomai G; Leibowitz A; Sharabi Y; Grossman E
    J Am Soc Hypertens; 2014 Jul; 8(7):498-502. PubMed ID: 24818617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Impact of On-Treatment Cumulative Ambulatory Blood Pressures for Adverse Macro- and Microvascular Outcomes in Individuals With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort.
    Cardoso CRL; Leite NC; Salles GF
    Hypertension; 2023 Oct; 80(10):2178-2186. PubMed ID: 37548035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term cumulative blood pressure in young adults and incident heart failure, coronary heart disease, stroke, and cardiovascular disease: The CARDIA study.
    Nwabuo CC; Appiah D; Moreira HT; Vasconcellos HD; Yano Y; Reis JP; Shah RV; Murthy VL; Allen NB; Sidney S; Muntner P; Lewis CE; Lloyd-Jones DM; Schreiner PJ; Gidding SS; Lima JAC
    Eur J Prev Cardiol; 2021 Oct; 28(13):1445-1451. PubMed ID: 34695218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk stratification with plasma B-type natriuretic peptide levels in a community-based hypertensive cohort.
    Sato K; Segawa T; Tanaka F; Takahashi T; Tanno K; Ohsawa M; Onoda T; Itai K; Sakata K; Omama S; Ogasawara K; Ishibashi Y; Makita S; Okayama A; Nakamura M
    Am J Cardiol; 2014 Feb; 113(4):682-6. PubMed ID: 24388621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study.
    Graversen P; Abildstrøm SZ; Jespersen L; Borglykke A; Prescott E
    Eur J Prev Cardiol; 2016 Sep; 23(14):1546-56. PubMed ID: 26976846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients.
    Mallamaci F; Tripepi G; D'Arrigo G; Borrelli S; Garofalo C; Stanzione G; Provenzano M; De Nicola L; Conte G; Minutolo R; Zoccali C
    Clin J Am Soc Nephrol; 2019 Feb; 14(2):233-240. PubMed ID: 30602461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Long-term Cumulative Blood Pressure in Cardiovascular Risk Prediction Models.
    Pool LR; Ning H; Wilkins J; Lloyd-Jones DM; Allen NB
    JAMA Cardiol; 2018 Nov; 3(11):1096-1100. PubMed ID: 30193291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
    Yeboah J; McClelland RL; Polonsky TS; Burke GL; Sibley CT; O'Leary D; Carr JJ; Goff DC; Greenland P; Herrington DM
    JAMA; 2012 Aug; 308(8):788-95. PubMed ID: 22910756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Number of blood pressure measurements needed to estimate long-term visit-to-visit systolic blood pressure variability for predicting cardiovascular risk: a 10-year retrospective cohort study in a primary care clinic in Malaysia.
    Lim HM; Chia YC; Ching SM; Chinna K
    BMJ Open; 2019 Apr; 9(4):e025322. PubMed ID: 31005918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulse wave velocity, pulse pressure and number of carotid or femoral plaques improve prediction of cardiovascular death in a population at low risk.
    Bérard E; Bongard V; Ruidavets JB; Amar J; Ferrières J
    J Hum Hypertens; 2013 Sep; 27(9):529-34. PubMed ID: 23426066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrocardiography score based on the Minnesota code classification system predicts cardiovascular mortality in an asymptomatic low-risk population.
    Kim WD; Lee Y; Kim BS; Kim HJ; Shin JH; Park JK; Park HC; Lim YH; Shin J
    Ann Med; 2023; 55(2):2288306. PubMed ID: 38052061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure variability: cardiovascular risk integrator or independent risk factor?
    Blacher J; Safar ME; Ly C; Szabo de Edelenyi F; Hercberg S; Galan P
    J Hum Hypertens; 2015 Feb; 29(2):122-6. PubMed ID: 24990422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additional value of B-type natriuretic peptide on discrimination of patients at risk for mortality after a non-ST-segment elevation acute coronary syndrome.
    García-Alvarez A; Regueiro A; Hernández J; Kasa G; Sitges M; Bosch X; Heras M
    Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):132-40. PubMed ID: 24448752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III.
    Shah N; Pahuja M; Pant S; Handa A; Agarwal V; Patel N; Dusaj R
    Int J Cardiol; 2017 Apr; 232():105-110. PubMed ID: 28117138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of ECG abnormalities and cardiovascular risk classification: a cohort study of primary care patients in the Netherlands.
    Groot A; Bots ML; Rutten FH; den Ruijter HM; Numans ME; Vaartjes I
    Br J Gen Pract; 2015 Jan; 65(630):e1-8. PubMed ID: 25548311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment: A Prospective Cohort Study.
    Laugesen E; Knudsen ST; Hansen KW; Rossen NB; Jensen LO; Hansen MG; Munkholm H; Thomsen KK; Søndergaard H; Bøttcher M; Raungaard B; Madsen M; Hulman A; Witte D; Bøtker HE; Poulsen PL
    Hypertension; 2016 Sep; 68(3):768-74. PubMed ID: 27402917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary endothelial function testing provides superior discrimination compared with standard clinical risk scoring in prediction of cardiovascular events.
    Reriani M; Sara JD; Flammer AJ; Gulati R; Li J; Rihal C; Lennon R; Lerman LO; Lerman A
    Coron Artery Dis; 2016 May; 27(3):213-20. PubMed ID: 26882018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure control measures and cardiovascular outcomes: a prospective hypertensive cohort.
    Sideris K; Andrikou I; Thomopoulos C; Tatakis F; Kariori M; Manta E; Kalos T; Soulaidopoulos S; Drogkaris S; Konstantinidis D; Tsioufis K
    Blood Press; 2022 Dec; 31(1):228-235. PubMed ID: 36123788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS).
    Matsubara Y; Kimachi M; Fukuma S; Onishi Y; Fukuhara S
    PLoS One; 2017; 12(3):e0173468. PubMed ID: 28273175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.